Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 10

1.

Nearby stop codons in exons of the neurofibromatosis type 1 gene are disparate splice effectors.

Hoffmeyer S, Nürnberg P, Ritter H, Fahsold R, Leistner W, Kaufmann D, Krone W.

Am J Hum Genet. 1998 Feb;62(2):269-77.

2.

The association of nonsense codons with exon skipping.

Valentine CR.

Mutat Res. 1998 Sep;411(2):87-117. Review.

PMID:
9806422
3.
4.

Mutation specific therapy in CF.

Kerem E.

Paediatr Respir Rev. 2006;7 Suppl 1:S166-9. Epub 2006 Jun 5. Review.

PMID:
16798551
5.

RNA processing and clinical variability in neurofibromatosis type I (NF1).

Skuse GR, Cappione AJ.

Hum Mol Genet. 1997;6(10):1707-12. Review.

6.

Alternative splicing of the neurofibromatosis type I pre-mRNA.

Barron VA, Lou H.

Biosci Rep. 2012 Apr 1;32(2):131-8. doi: 10.1042/BSR20110060. Review.

7.

Pharmaceuticals targeting nonsense mutations in genetic diseases: progress in development.

Rowe SM, Clancy JP.

BioDrugs. 2009;23(3):165-74. doi: 10.2165/00063030-200923030-00003. Review.

PMID:
19627168
8.

Chain termination codons and polymerase-induced frameshift mutations.

Jestin JL, Kempf A.

FEBS Lett. 1997 Dec 15;419(2-3):153-6. Review.

9.

The neurofibromatosis type 1 gene and its protein product, neurofibromin.

Gutmann DH, Collins FS.

Neuron. 1993 Mar;10(3):335-43. Review. No abstract available.

PMID:
8461130
10.

Latent splice sites and stop codons revisited.

Zhang XH, Chasin LA.

RNA. 2004 Jan;10(1):5-6. Review.

Items per page

Supplemental Content

Write to the Help Desk